Loading clinical trials...
Loading clinical trials...
Multicenter Phase II Study for International Intraocular Retinoblastoma Classification Groups B, C & D Tumors Treated With Carboplatin-Etoposide-Vincristine-Cyclosporine-Focal Therapy Multimodality Protocol (OCRN Multicenter RB 2003)
Conditions
Interventions
filgrastim
Carboplatin
+5 more
Locations
6
Canada
Children's and Women's Hospital of British Columbia
Vancouver, British Columbia, Canada
Hospital for Sick Children
Toronto, Ontario, Canada
Montreal Children's Hospital at McGill University Health Center
Montreal, Quebec, Canada
Hospital San Juan de Dios
Santiago, Chile
Sankara Nethralaya Super Specialty Clinic
Chennai, India
Kandang Kerbau Women's and Children's Hospital
Singapore, Singapore
Start Date
June 1, 2004
Primary Completion Date
April 20, 2016
Completion Date
December 31, 2024
Last Updated
April 17, 2024
NCT06679634
NCT03050268
NCT03267459
NCT06424301
NCT06972602
NCT02870907
Lead Sponsor
The Hospital for Sick Children
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions